Earnings Feed
Start Free
Home/Filings/4/0001562180-17-003384
4//SEC Filing

Bazan J. Fernando 4

Accession 0001562180-17-003384

CIK 0000842023other
View on SEC.govCompany Profile

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 5:08 PM ET

Size

23.6 KB

Accession

0001562180-17-003384

Insider Transaction Report

Form 4
Period: 2017-10-26
BIO-TECHNE CorpTECH
Bazan J. Fernando
Chief Technical Officer
Transactions
  • Award

    Stock Options (Right to buy)

    2017-10-26+9,089→ 9,089 total
    Exercise: $125.05Exp: 2024-08-09→ Common Stock (9,089 underlying)
  • Award

    Restricted Stock Units

    2017-10-26+1,649→ 1,649 total
    → Common Stock (1,649 underlying)
  • Award

    Stock Options (Right to buy)

    2017-10-26+12,119→ 12,119 total
    Exercise: $125.05Exp: 2024-08-09→ Common Stock (12,119 underlying)
Holdings

  • Restricted Stock Units

    → Common Stock (1,759 underlying)
    1,759

  • Stock Options (Right to buy)

    Exercise: $106.59Exp: 2023-08-18→ Common Stock (14,476 underlying)
    14,476

  • Stock Options (Right to buy)

    Exercise: $106.59Exp: 2023-08-18→ Common Stock (10,857 underlying)
    10,857

  • Restricted Stock Units

    → Common Stock (1,200 underlying)
    1,200

  • Stock Option (Right to Buy)

    Exercise: $76.02From: 2016-08-01Exp: 2020-07-31→ Common Stock (10,000 underlying)
    10,000

  • Stock Option (Right to Buy)

    Exercise: $108.49Exp: 2022-08-07→ Common Stock (10,000 underlying)
    10,000

  • Stock Option (Right to Buy)

    Exercise: $94.35Exp: 2021-08-12→ Common Stock (15,000 underlying)
    15,000

  • Stock Option (Right to Buy)

    Exercise: $76.02From: 2017-08-01Exp: 2020-07-31→ Common Stock (15,000 underlying)
    15,000

  • Stock Options (Right to Buy)

    Exercise: $108.49Exp: 2022-08-07→ Common Stock (7,500 underlying)
    7,500
Footnotes (8)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F2]Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F3]Vests 3,029 shares on 8/9/2018 and 3,030 shares each on 8/9/2019, 8/9/2020 and 8/9/2021
  • [F4]Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F5]Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F6]Vests 2,500 shares on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
  • [F7]Vests 3,750 shares on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
  • [F8]Vests 3,619 shares on each 8/18/17, 8/18/18, 8/18/19 and 8/18/20.

Documents

2 files

Issuer

BIO-TECHNE Corp

CIK 0000842023

→
Entity typeother

Related Parties

1
  • filerCIK 0001583204

Filing Metadata

Form type
4
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 5:08 PM ET
Size
23.6 KB
View on SEC.gov